(18)F-fluoro-L-thymidine-PET for the evaluation of primary brain tumours in children: a report of three cases.
until further notice
SourceNuclear Medicine Communications, 31, 6, (2010), pp. 482-487
1 juni 2010
Article / Letter to editor
Display more detailsDisplay less details
Paediatrics - OUD tm 2017
Nuclear Medicine Communications
SubjectONCOL 2: Age-related aspects of cancer; ONCOL 3: Translational research
BACKGROUND: F-fluoro-L-thymidine (FLT) has been shown to be a useful PET tracer in the evaluation of brain tumours in adults. No studies of this modality in children with brain tumours, however, have been published. OBJECTIVE: In this report three children with brain tumours are presented in which FLT-PET was used for different diagnostic purposes, in addition to imaging with MRI and F-fluorodeoxyglucose-PET. The first patient showed that FLT-PET could be helpful in differentiating between infection and malignancy. In the second patient FLT-PET was used for differentiating recurrent disease from radiotherapy effects. In the third patient, in which biopsy was not possible, FLT-PET was used for the characterization of the tumour. CONCLUSION: These patients show that FLT-PET might be a useful modality in different stages of the evaluation of primary brain tumours in children. However, further research to determine the clinical value, relative to MRI and fluorodeoxyglucose-PET, is required before routine implementation of FLT-PET.
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.